Man Group
MRVI icon

Man Group’s Maravai LifeSciences MRVI Stock Holding History

Man Group’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-50,569
Closed -$331K – 2219
2023
Q4 		$331K Buy
+50,569
New +$327K ﹤0.01% 1788
2023
Q3 		– Sell
-27,370
Closed -$301K – 1763
2023
Q2 		$340K Buy
+27,370
New +$369K ﹤0.01% 1690
2023
Q1 		– Hold
0
– – – 1678
2021
Q4 		– Sell
-22,450
Closed -$1.1M – 2048
2021
Q3 		$1.1M Buy
22,450
+10,943
+95% +$534K ﹤0.01% 1317
2021
Q2 		$481K Sell
11,507
-9,731
-46% -$377K ﹤0.01% 1570
2021
Q1 		$757K Buy
+21,238
New +$704K ﹤0.01% 1366

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Man Group's MRVI Position: Q1 2024 in Review

Man Group sold out of Maravai LifeSciences (MRVI) in Q1 2024, closing a stake of 50,569 shares — an estimated $331K sold.

Man Group first reported a position in MRVI in Q1 2021 and held it in 5 quarters. The position peaked at $1.1M in Q3 2021. 210 funds tracked by Wall St. Rank hold MRVI as of Q1 2024.

  • Man Group reported no remaining Maravai LifeSciences position as of Q1 2024 after selling out during the quarter.
  • Man Group sold 50,569 Maravai LifeSciences shares in Q1 2024, an estimated $331K.
  • Man Group first reported a position in Maravai LifeSciences in Q1 2021 and held it in 5 quarters.
  • Man Group's Maravai LifeSciences position peaked at $1.1M in Q3 2021.
  • 210 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2024.

Based on Man Group's 13F filing for Q1 2024, filed 15 May 2024.